Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS research · 2018-06-06

Clinical Trial Update: Does Urinary TIMP2 and IGFBP7 Can Identify High Risk Patients of Progression From Mild and Moderate to Severe Acute Kidney Injury During Septic Shock?

View source ↗

Summary

This clinical trial update investigates whether urinary TIMP2 and IGFBP7 biomarkers can identify patients with septic shock and early acute kidney injury who ar…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Snippet

Sponsor: Centre Hospitalier Universitaire, Amiens | Conditions: Acute Kidney Injury, Septic Shock | Status: UNKNOWN